• Documents
  • Authors
  • Tables
  • Log in
  • Sign up
  • MetaCart
  • DMCA
  • Donate

CiteSeerX logo

Advanced Search Include Citations
Advanced Search Include Citations

Molecular pathways and targets in prostate cancer. Oncotarget (0)

by E Shtivelman, Beer TM, Evans CP
Add To MetaCart

Tools

Sorted by:
Results 1 - 3 of 3

*These authors have contributed equally to this work Correspondence to:

by Ying Wang, Jianguang Zhou, Shanhu Li, Shanhu Li
"... www.impactjournals.com/oncotarget / Oncotarget, Vol. 6, No. 24 PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability ..."
Abstract - Add to MetaCart
www.impactjournals.com/oncotarget / Oncotarget, Vol. 6, No. 24 PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability
(Show Context)

Citation Context

...simprovements in early screening and treatment, PCa issdiagnosed in 240,000 men and causes 30,000 deathssper year in the US [2]. Most patients die from advancedsPCa, which is still difficult to treat =-=[3]-=-. Understandingsmolecular events involved in PCa progression willsenable us to experiment with novel therapies. PTEN, astumor suppressor protein, is often mutated or deleted insadvanced PCa, activatin...

Distributed under Creative Commons CC-BY 4.0 OPEN ACCESS

by Nicole Perfito, Esta Sterneck, Denise Chronscinski, Srujana Cherukeri, Fraser Tan, Nicole Perfito, Joelle Lomax, Elizabeth Iorns , 2015
"... Declarations can be found on page 13 DOI 10.7717/peerj.1231 Copyright 2015 Chronscinski et al. ..."
Abstract - Add to MetaCart
Declarations can be found on page 13 DOI 10.7717/peerj.1231 Copyright 2015 Chronscinski et al.

unknown title

by unknown authors
"... Prostate cancer is the most commonly diagnosed non-cutaneous malignancy in men and remains the second-leading cause of cancer-related death in men (1,2). Despite advances in screening for and early detection of prostate ..."
Abstract - Add to MetaCart
Prostate cancer is the most commonly diagnosed non-cutaneous malignancy in men and remains the second-leading cause of cancer-related death in men (1,2). Despite advances in screening for and early detection of prostate
Powered by: Apache Solr
  • About CiteSeerX
  • Submit and Index Documents
  • Privacy Policy
  • Help
  • Data
  • Source
  • Contact Us

Developed at and hosted by The College of Information Sciences and Technology

© 2007-2019 The Pennsylvania State University